Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Multiple Myeloma
Title
Refractory to Lenalidomide
Description
A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma

Multiple Myeloma - PO-MM-PI-0049/Oncotherapeutics
IRB Number
NCT01541332
Inclusion/Notes

For more information, please click here: http://www.clinicaltrials.gov/ct2/show/NCT01541332?term=NCT01541332&rank=1

Status
Open to Enrollment
Principal Investigator
Thomas B Woliver, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.